NORTH AMERICA DIGITAL POLYMERASE CHAIN REACTION MARKET FORECAST 2017-2025
KEY FINDINGS
The North America digital PCR market generated a revenue of $107 million in 2016. The market is expected to grow at a CAGR of 31.90% and account for the highest market share by generating $1400 million by the end of 2025.
MARKET INSIGHTS
Factors like growing hospitals and diagnostic centers across the US and Canada and the increase in public and private funding for the development of R&D innovation in digital PCR products are responsible for the expansion of the market in this region. The market is segmented on the basis of application (clinical, research and forensics), end-users (research & academic institution, pharmaceuticals & biotechnology, clinical, research organization, forensic laboratories) and products &services (instruments, reagents & consumables and software & services). The rise of genome technology in the region is expected to provide the market with phenomenal growth opportunities in the near future.
COMPETITIVE INSIGHTS
Some of the prominent players in the market are: Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biomerieux S.A, Mdx Health, Pacific Biosciences of California, Inc, Nanobiosys Inc., and Thermo Fisher Scientific Inc
The North America digital PCR market generated a revenue of $107 million in 2016. The market is expected to grow at a CAGR of 31.90% and account for the highest market share by generating $1400 million by the end of 2025.
MARKET INSIGHTS
Factors like growing hospitals and diagnostic centers across the US and Canada and the increase in public and private funding for the development of R&D innovation in digital PCR products are responsible for the expansion of the market in this region. The market is segmented on the basis of application (clinical, research and forensics), end-users (research & academic institution, pharmaceuticals & biotechnology, clinical, research organization, forensic laboratories) and products &services (instruments, reagents & consumables and software & services). The rise of genome technology in the region is expected to provide the market with phenomenal growth opportunities in the near future.
COMPETITIVE INSIGHTS
Some of the prominent players in the market are: Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biomerieux S.A, Mdx Health, Pacific Biosciences of California, Inc, Nanobiosys Inc., and Thermo Fisher Scientific Inc
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
4. MARKET DYNAMICS
4.1. DRIVERS
4.1.1. INCREASING INCIDENTS OF INFECTIOUS DISEASES AND GENETIC DISORDERS
4.1.2. INCREASING ELDERLY POPULATION
4.1.3. RISING GERIATRIC POPULATION
4.1.4. INCREASING PUBLIC–PRIVATE INVESTMENTS AND GRANTS
4.1.5. RISE IN THE NUMBER OF HOSPITALS AND DIAGNOSTICS CENTERS
4.2. RESTRAINTS
4.2.1. HIGH DEVICE COSTS ASSOCIATED WITH DPCR
4.2.2. NEED TO TRAINING AND UPDATATION OF LABORATORIES WORKERS
4.3. OPPORTUNITIES
4.3.1. RISE IN GENOME TECHNOLOGY
4.4. CHALLENGES
4.4.1. IMPLEMENTATION OF MIQE GUIDELINES FOR PUBLISHING DPCR-BASED RESEARCH
4.4.2. INCREASING AVAILABILITY OF ALTERNATIVE TECHNOLOGIES
5. POLYMERASE CHAIN REACTION MARKET BY TECHNOLOGY
5.1. DIGITAL PCR (DPCR)
5.2. QUANTITATIVE PCR (QPCR)
6. MARKET SEGMENTATION
6.1. MARKET BY PRODUCT AND SERVICES 2017-2025
6.1.1. INSTRUMENTS
6.1.2. REAGENTS & CONSUMABLES
6.1.3. SOFTWARE & SERVICES
6.2. MARKET BY APPLICATION 2017-2025
6.2.1. CLINICAL
6.2.2. RESEARCH
6.2.3. FORENSIC
6.3. MARKET BY END USER 2017-2025
6.3.1. RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
6.3.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.3.3. CLINICAL RESEARCH ORGANISATION
6.3.4. FORENSIC LABORATORIES
7. KEY ANALYTICAL
7.1. KEY MARKET INSIGHTS
7.1.1. FAST GROWING COUNTRIES
7.1.2. MARKET TRENDS
7.2. OPPORTUNITY MATRIX
7.3. VENDOR LANDSCAPE
8. GEOGRAPHIC ANALYSIS
8.1. NORTH AMERICA
8.1.1. UNITED STATES (U.S.)
8.1.2. CANADA
9. COMPANY PROFILES
9.1. COMPETITIVE LANDSCAPE
9.1.1. MARKET SHARE ANALYSIS
9.1.2. TOP WINNING STRATEGIES
9.2. AFFYMETRIX, INC.
9.3. AGILENT TECHNOLOGIES, INC.
9.4. BIOMERIEUX S.A.
9.5. BIO-RAD LABORATORIES, INC.
9.6. F. HOFFMAN-LA ROCHE LTD
9.7. FLUIDIGM CORPORATION
9.8. GENNOVA SCIENTIFIC SL
9.9. MDX HEALTH
9.10. NANOBIOSYS INC.
9.11. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
9.12. QIAGEN N.V
9.13. RAINDANCE TECHNOLOGIES, INC. (ACQUIRED BY BIO-RAD LABORATORIES, INC)
9.14. TAKARA BIO, INC.
9.15. THERMO FISHER SCIENTIFIC INC
9.16. Z-BIOMED INC
9.17. STRATEGIC RECOMMENDATION & CONCLUSION
TABLE LIST
TABLE 1 NORTH AMERICA DIGITAL PCR MARKET 2017-2025 ($MILLION)
TABLE 2 PRICES OF QPCR VS DPCR DEVICES
TABLE 3 NORTH AMERICA DIGITAL PCR MARKET BY PRODUCT AND SERVICES 2017-2025 ($MILLION)
TABLE 4 NORTH AMERICA INSTRUMENTS MARKET 2017-2025 ($MIILION)
TABLE 5 NORTH AMERICA REAGENTS AND CONSUMABLE MARKET 2017-2025($MILLION)
TABLE 6 NORTH AMERICA SOFTWARE & SERVICES MARKET 2017-2025 ($MILLION)
TABLE 7 NORTH AMERICA DIGITAL PCR MARKET BY APPLICATION 2017-2025 ($MILLION)
TABLE 8 NORTH AMERICA DPCR CLINICAL APPLICATION MARKET 2017-2025 ($MILLION)
TABLE 9 NORTH AMERICA RESEARCH MARKET 2017-2025 ($MILLION)
TABLE 10 NORTH AMERICA FORENSIC MARKET 2017-2025 ($MILLION)
TABLE 11 NORTH AMERICA DIGITAL PCR MARKET BY END USER 2017-2025 ($MILLION)
TABLE 12 NORTH AMERICA RESEARCH LABORATORY AND ACADEMIC INTITUTES MARKET 2017-2025 ($MILLION)
TABLE 13 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025 ($MILLION)
TABLE 14 NORTH AMERICA CLINICAL RESEARCH ORGANISATIONS MARKET ($2017-2025)
TABLE 15 NORTH AMERICA FORENSIC LABORATOTY MARKET 2017-2025 ($MILLION)
TABLE 16 NORTH AMERICA DIGITAL PCR MARKET BY COUNTRIES 2017-2025 ($MILLION)
TABLE 17 DEMOGRAPHIC PROFILES OF SENIOR CITIZENS OVER THE XII PLAN PERIOD
FIGURES LIST
FIGURE 1 NUMBER OF CANCER CASES AROUND THE WORLD (IN MILLION)
FIGURE 2 INCIDENCE OF PEOPLE WITH HIV
FIGURE 3 TOTAL HEALTH EXPENDITURE PER CAPITA IN US DOLLARS
FIGURE 4 NUMBER OF HOSPITALS (2015)
FIGURE 5 NORTH AMERICA INSTRUMENT MARKET 2017-2025 ($MILLION)
FIGURE 6 NORTH AMERICA REAGENTS & CONSUMABLES MARKET 2017-2025 ($MILLION)
FIGURE 7 NORTH AMERICA SOFTWARE & SERVICES MARKET 2017-2025 ($MILLION)
FIGURE 8 NORTH AMERICA CLINICAL MARKET 2017-2025 ($MILLION)
FIGURE 9 TOTAL US MEDICAL AND HEALTH R&D SPENDING ($MILLION)
FIGURE 10 NORTH AMERICA RESEARCH MARKET 2017-2025 ($MILLION)
FIGURE 11 NORTH AMERICA FORENSIC MARKET 2017-2025 ($MILLION)
FIGURE 12 ACADEMIC AND RESEARCH INSTITUTION FUND IN USA ($MILLION)
FIGURE 13 NORTH AMERICA RESEARCH LABORATORY AND ACADEMIC INSTITUTES MARKET 2017-2025 ($MILLION)
FIGURE 14 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES MARKET 2017-2025 ($MILLION)
FIGURE 15 NORTH AMERICA CLINICAL RESEARCH ORGANIZATION MARKET 2017-2025 ($MILLION)
FIGURE 16 NORTH AMERICA FORENSIC LABORATORIES MARKET 2017-2025 ($MILLION)
FIGURE 17 POPULATION OF NORTH AMERICA 2016 (MILLION)
FIGURE 18 PERCENT OF POPULATION WITH AGE
FIGURE 19 UNITED STATES (U.S.) DIGITAL PCR MARKET 2017-2025 ($MILLION)
FIGURE 20 NUMBER OF PERSONS 65+, 2014 TO 2023 (NO. IN MILLIONS)
FIGURE 21 CANADA DIGITAL PCR MARKET 2017-2025 ($MILLION)
FIGURE 22 MARKET SHARE ANALYSES OF KEY PLAYERS IN DIGITAL PCR MARKET 2016
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
4. MARKET DYNAMICS
4.1. DRIVERS
4.1.1. INCREASING INCIDENTS OF INFECTIOUS DISEASES AND GENETIC DISORDERS
4.1.2. INCREASING ELDERLY POPULATION
4.1.3. RISING GERIATRIC POPULATION
4.1.4. INCREASING PUBLIC–PRIVATE INVESTMENTS AND GRANTS
4.1.5. RISE IN THE NUMBER OF HOSPITALS AND DIAGNOSTICS CENTERS
4.2. RESTRAINTS
4.2.1. HIGH DEVICE COSTS ASSOCIATED WITH DPCR
4.2.2. NEED TO TRAINING AND UPDATATION OF LABORATORIES WORKERS
4.3. OPPORTUNITIES
4.3.1. RISE IN GENOME TECHNOLOGY
4.4. CHALLENGES
4.4.1. IMPLEMENTATION OF MIQE GUIDELINES FOR PUBLISHING DPCR-BASED RESEARCH
4.4.2. INCREASING AVAILABILITY OF ALTERNATIVE TECHNOLOGIES
5. POLYMERASE CHAIN REACTION MARKET BY TECHNOLOGY
5.1. DIGITAL PCR (DPCR)
5.2. QUANTITATIVE PCR (QPCR)
6. MARKET SEGMENTATION
6.1. MARKET BY PRODUCT AND SERVICES 2017-2025
6.1.1. INSTRUMENTS
6.1.2. REAGENTS & CONSUMABLES
6.1.3. SOFTWARE & SERVICES
6.2. MARKET BY APPLICATION 2017-2025
6.2.1. CLINICAL
6.2.2. RESEARCH
6.2.3. FORENSIC
6.3. MARKET BY END USER 2017-2025
6.3.1. RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
6.3.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.3.3. CLINICAL RESEARCH ORGANISATION
6.3.4. FORENSIC LABORATORIES
7. KEY ANALYTICAL
7.1. KEY MARKET INSIGHTS
7.1.1. FAST GROWING COUNTRIES
7.1.2. MARKET TRENDS
7.2. OPPORTUNITY MATRIX
7.3. VENDOR LANDSCAPE
8. GEOGRAPHIC ANALYSIS
8.1. NORTH AMERICA
8.1.1. UNITED STATES (U.S.)
8.1.2. CANADA
9. COMPANY PROFILES
9.1. COMPETITIVE LANDSCAPE
9.1.1. MARKET SHARE ANALYSIS
9.1.2. TOP WINNING STRATEGIES
9.2. AFFYMETRIX, INC.
9.3. AGILENT TECHNOLOGIES, INC.
9.4. BIOMERIEUX S.A.
9.5. BIO-RAD LABORATORIES, INC.
9.6. F. HOFFMAN-LA ROCHE LTD
9.7. FLUIDIGM CORPORATION
9.8. GENNOVA SCIENTIFIC SL
9.9. MDX HEALTH
9.10. NANOBIOSYS INC.
9.11. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
9.12. QIAGEN N.V
9.13. RAINDANCE TECHNOLOGIES, INC. (ACQUIRED BY BIO-RAD LABORATORIES, INC)
9.14. TAKARA BIO, INC.
9.15. THERMO FISHER SCIENTIFIC INC
9.16. Z-BIOMED INC
9.17. STRATEGIC RECOMMENDATION & CONCLUSION
TABLE LIST
TABLE 1 NORTH AMERICA DIGITAL PCR MARKET 2017-2025 ($MILLION)
TABLE 2 PRICES OF QPCR VS DPCR DEVICES
TABLE 3 NORTH AMERICA DIGITAL PCR MARKET BY PRODUCT AND SERVICES 2017-2025 ($MILLION)
TABLE 4 NORTH AMERICA INSTRUMENTS MARKET 2017-2025 ($MIILION)
TABLE 5 NORTH AMERICA REAGENTS AND CONSUMABLE MARKET 2017-2025($MILLION)
TABLE 6 NORTH AMERICA SOFTWARE & SERVICES MARKET 2017-2025 ($MILLION)
TABLE 7 NORTH AMERICA DIGITAL PCR MARKET BY APPLICATION 2017-2025 ($MILLION)
TABLE 8 NORTH AMERICA DPCR CLINICAL APPLICATION MARKET 2017-2025 ($MILLION)
TABLE 9 NORTH AMERICA RESEARCH MARKET 2017-2025 ($MILLION)
TABLE 10 NORTH AMERICA FORENSIC MARKET 2017-2025 ($MILLION)
TABLE 11 NORTH AMERICA DIGITAL PCR MARKET BY END USER 2017-2025 ($MILLION)
TABLE 12 NORTH AMERICA RESEARCH LABORATORY AND ACADEMIC INTITUTES MARKET 2017-2025 ($MILLION)
TABLE 13 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025 ($MILLION)
TABLE 14 NORTH AMERICA CLINICAL RESEARCH ORGANISATIONS MARKET ($2017-2025)
TABLE 15 NORTH AMERICA FORENSIC LABORATOTY MARKET 2017-2025 ($MILLION)
TABLE 16 NORTH AMERICA DIGITAL PCR MARKET BY COUNTRIES 2017-2025 ($MILLION)
TABLE 17 DEMOGRAPHIC PROFILES OF SENIOR CITIZENS OVER THE XII PLAN PERIOD
FIGURES LIST
FIGURE 1 NUMBER OF CANCER CASES AROUND THE WORLD (IN MILLION)
FIGURE 2 INCIDENCE OF PEOPLE WITH HIV
FIGURE 3 TOTAL HEALTH EXPENDITURE PER CAPITA IN US DOLLARS
FIGURE 4 NUMBER OF HOSPITALS (2015)
FIGURE 5 NORTH AMERICA INSTRUMENT MARKET 2017-2025 ($MILLION)
FIGURE 6 NORTH AMERICA REAGENTS & CONSUMABLES MARKET 2017-2025 ($MILLION)
FIGURE 7 NORTH AMERICA SOFTWARE & SERVICES MARKET 2017-2025 ($MILLION)
FIGURE 8 NORTH AMERICA CLINICAL MARKET 2017-2025 ($MILLION)
FIGURE 9 TOTAL US MEDICAL AND HEALTH R&D SPENDING ($MILLION)
FIGURE 10 NORTH AMERICA RESEARCH MARKET 2017-2025 ($MILLION)
FIGURE 11 NORTH AMERICA FORENSIC MARKET 2017-2025 ($MILLION)
FIGURE 12 ACADEMIC AND RESEARCH INSTITUTION FUND IN USA ($MILLION)
FIGURE 13 NORTH AMERICA RESEARCH LABORATORY AND ACADEMIC INSTITUTES MARKET 2017-2025 ($MILLION)
FIGURE 14 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES MARKET 2017-2025 ($MILLION)
FIGURE 15 NORTH AMERICA CLINICAL RESEARCH ORGANIZATION MARKET 2017-2025 ($MILLION)
FIGURE 16 NORTH AMERICA FORENSIC LABORATORIES MARKET 2017-2025 ($MILLION)
FIGURE 17 POPULATION OF NORTH AMERICA 2016 (MILLION)
FIGURE 18 PERCENT OF POPULATION WITH AGE
FIGURE 19 UNITED STATES (U.S.) DIGITAL PCR MARKET 2017-2025 ($MILLION)
FIGURE 20 NUMBER OF PERSONS 65+, 2014 TO 2023 (NO. IN MILLIONS)
FIGURE 21 CANADA DIGITAL PCR MARKET 2017-2025 ($MILLION)
FIGURE 22 MARKET SHARE ANALYSES OF KEY PLAYERS IN DIGITAL PCR MARKET 2016